MEDI 488
Latest Information Update: 09 Aug 2021
At a glance
- Originator MedImmune
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action HIV envelope protein gp120 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 20 Jan 2000 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
- 06 Jul 1998 No-Development-Reported for HIV infections treatment in USA (Unknown route)